Table 1.
Baseline Demographic Characteristics
| All Patients (N=5906) | Oral (n=1701) | Injectable (n=3748) | Infusion (n=457) | |
|---|---|---|---|---|
| Age, mean (SD), y | 46.6 (12.4) | 47.8 (12.1) | 46.3 (12.6) | 45.1 (11.6) |
| Sex, n (%) | ||||
| Male | 1526 (25.8) | 429 (25.2) | 969 (25.9) | 128 (28.0) |
| Female | 4380 (74.2) | 1272 (74.8) | 2779 (74.2) | 329 (72.0) |
| Race, n (%) | ||||
| Asian | 69 (1.2) | 19 (1.1) | 43 (1.2) | 7 (1.5) |
| Black | 603 (10.2) | 162 (9.5) | 396 (10.6) | 45 (9.9) |
| Hispanic | 387 (6.6) | 112 (6.6) | 256 (6.8) | 19 (4.2) |
| White | 3957 (67.0) | 1132 (66.6) | 2505 (66.8) | 320 (70.0) |
| Unknown | 890 (15.1) | 276 (16.2) | 548 (14.6) | 66 (14.4) |
| Payer, n (%) | ||||
| Commercial | 4285 (72.6) | 1158 (68.1) | 2808 (74.9) | 319 (69.8) |
| Medicare | 1621 (27.5) | 543 (31.9) | 940 (25.1) | 138 (30.2) |
| Index year | ||||
| 2010 | 771 (13.1) | 8 (0.5) | 724 (19.3) | 39 (8.5) |
| 2011 | 812 (13.8) | 78 (4.6) | 673 (18.0) | 61 (13.4) |
| 2012 | 771 (13.1) | 66 (3.9) | 627 (16.7) | 78 (17.1) |
| 2013 | 795 (13.5) | 283 (16.6) | 455 (12.1) | 57 (12.5) |
| 2014 | 761 (12.9) | 380 (22.3) | 335 (8.9) | 46 (10.1) |
| 2015 | 811 (13.7) | 330 (19.4) | 425 (11.3) | 56 (12.3) |
| 2016 | 580 (9.8) | 270 (15.9) | 256 (6.8) | 54 (11.8) |
| 2017 | 605 (10.2) | 286 (16.8) | 253 (6.8) | 66 (14.4) |